Clinical trial
Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction
NCT02835781 is registered in ClinicalTrials.gov with University Hospital Bratislava as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogenic Acellular Dermal Matrix Use in Patients With Breast Reconstruction
- Lead sponsor
- University Hospital Bratislava
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- June 30, 2016
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer